Modification  ||| S:0 E:13 ||| NNP
and  ||| S:13 E:17 ||| CC
implementation  ||| S:17 E:32 ||| NN
of  ||| S:32 E:35 ||| IN
NCCN  ||| S:35 E:40 ||| NNP
Guidelines  ||| S:40 E:51 ||| NNP
on  ||| S:51 E:54 ||| IN
palliative  ||| S:54 E:65 ||| JJ
care  ||| S:65 E:70 ||| NN
in  ||| S:70 E:73 ||| IN
the  ||| S:73 E:77 ||| DT
Middle  ||| S:77 E:84 ||| NNP
East  ||| S:84 E:89 ||| NNP
and  ||| S:89 E:93 ||| CC
North  ||| S:93 E:99 ||| NNP
Africa  ||| S:99 E:106 ||| NNP
region  ||| S:106 E:113 ||| NN
Palliative  ||| S:113 E:124 ||| NNP
care  ||| S:124 E:129 ||| NN
is  ||| S:129 E:132 ||| VBZ
an  ||| S:132 E:135 ||| DT
important  ||| S:135 E:145 ||| JJ
component  ||| S:145 E:155 ||| NN
of  ||| S:155 E:158 ||| IN
cancer  ||| S:158 E:165 ||| NN
treatment ||| S:165 E:174 ||| NN
.  ||| S:174 E:176 ||| .
Advancing  ||| S:176 E:186 ||| VBG
palliative  ||| S:186 E:197 ||| JJ
care  ||| S:197 E:202 ||| NN
in  ||| S:202 E:205 ||| IN
the  ||| S:205 E:209 ||| DT
developing  ||| S:209 E:220 ||| VBG
countries  ||| S:220 E:230 ||| NNS
is  ||| S:230 E:233 ||| VBZ
essential  ||| S:233 E:243 ||| JJ
to  ||| S:243 E:246 ||| TO
improving  ||| S:246 E:256 ||| VBG
patient  ||| S:256 E:264 ||| JJ
care ||| S:264 E:268 ||| NN
.  ||| S:268 E:270 ||| .
The  ||| S:270 E:274 ||| DT
issues  ||| S:274 E:281 ||| NNS
limiting  ||| S:281 E:290 ||| VBG
its  ||| S:290 E:294 ||| PRP$
practice  ||| S:294 E:303 ||| NN
must  ||| S:303 E:308 ||| MD
be  ||| S:308 E:311 ||| VB
addressed ||| S:311 E:320 ||| VBN
,  ||| S:320 E:322 ||| ,
especially  ||| S:322 E:333 ||| RB
in  ||| S:333 E:336 ||| IN
light  ||| S:336 E:342 ||| NN
of  ||| S:342 E:345 ||| IN
the  ||| S:345 E:349 ||| DT
initiative  ||| S:349 E:360 ||| NN
to  ||| S:360 E:363 ||| TO
adapt  ||| S:363 E:369 ||| VB
the  ||| S:369 E:373 ||| DT
NCCN  ||| S:373 E:378 ||| NNP
Clinical  ||| S:378 E:387 ||| NNP
Practice  ||| S:387 E:396 ||| NNP
Guidelines  ||| S:396 E:407 ||| NNP
in  ||| S:407 E:410 ||| IN
Oncology  ||| S:410 E:419 ||| NNP
( ||| S:419 E:420 ||| -LRB-
NCCN  ||| S:420 E:425 ||| NNP
Guidelines ||| S:425 E:435 ||| NNP
)  ||| S:435 E:437 ||| -RRB-
to  ||| S:437 E:440 ||| TO
the  ||| S:440 E:444 ||| DT
Middle  ||| S:444 E:451 ||| NNP
East  ||| S:451 E:456 ||| NNP
and  ||| S:456 E:460 ||| CC
North  ||| S:460 E:466 ||| NNP
Africa  ||| S:466 E:473 ||| NNP
( ||| S:473 E:474 ||| -LRB-
MENA ||| S:474 E:478 ||| NNP
)  ||| S:478 E:480 ||| -RRB-
region ||| S:480 E:486 ||| NN
.  ||| S:486 E:488 ||| .
Palliative  ||| S:488 E:499 ||| JJ
care  ||| S:499 E:504 ||| NN
is  ||| S:504 E:507 ||| VBZ
in  ||| S:507 E:510 ||| IN
its  ||| S:510 E:514 ||| PRP$
early  ||| S:514 E:520 ||| JJ
stage  ||| S:520 E:526 ||| NN
of  ||| S:526 E:529 ||| IN
evolution  ||| S:529 E:539 ||| NN
in  ||| S:539 E:542 ||| IN
the  ||| S:542 E:546 ||| DT
MENA  ||| S:546 E:551 ||| NNP
region ||| S:551 E:557 ||| NN
,  ||| S:557 E:559 ||| ,
and  ||| S:559 E:563 ||| CC
its  ||| S:563 E:567 ||| PRP$
practice  ||| S:567 E:576 ||| NN
encounters  ||| S:576 E:587 ||| VBZ
many  ||| S:587 E:592 ||| JJ
challenges  ||| S:592 E:603 ||| NNS
and  ||| S:603 E:607 ||| CC
barriers ||| S:607 E:615 ||| NNS
.  ||| S:615 E:617 ||| .
Adaptation  ||| S:617 E:628 ||| NN
of  ||| S:628 E:631 ||| IN
guidelines  ||| S:631 E:642 ||| NNS
should  ||| S:642 E:649 ||| MD
take  ||| S:649 E:654 ||| VB
into  ||| S:654 E:659 ||| IN
consideration  ||| S:659 E:673 ||| NN
the  ||| S:673 E:677 ||| DT
situation  ||| S:677 E:687 ||| NN
and  ||| S:687 E:691 ||| CC
conditions  ||| S:691 E:702 ||| NNS
in  ||| S:702 E:705 ||| IN
the  ||| S:705 E:709 ||| DT
targeted  ||| S:709 E:718 ||| JJ
region  ||| S:718 E:725 ||| NN
to  ||| S:725 E:728 ||| TO
improve  ||| S:728 E:736 ||| VB
the  ||| S:736 E:740 ||| DT
standard  ||| S:740 E:749 ||| NN
of  ||| S:749 E:752 ||| IN
care  ||| S:752 E:757 ||| NN
to  ||| S:757 E:760 ||| TO
an  ||| S:760 E:763 ||| DT
internationally  ||| S:763 E:779 ||| RB
acceptable  ||| S:779 E:790 ||| JJ
level ||| S:790 E:795 ||| NN
.  ||| S:795 E:797 ||| .
A  ||| S:797 E:799 ||| DT
group  ||| S:799 E:805 ||| NN
of  ||| S:805 E:808 ||| IN
experts  ||| S:808 E:816 ||| NNS
in  ||| S:816 E:819 ||| IN
the  ||| S:819 E:823 ||| DT
MENA  ||| S:823 E:828 ||| NNP
region  ||| S:828 E:835 ||| NN
reviewed  ||| S:835 E:844 ||| VBN
the  ||| S:844 E:848 ||| DT
literature  ||| S:848 E:859 ||| NN
and  ||| S:859 E:863 ||| CC
collaborated  ||| S:863 E:876 ||| VBD
to  ||| S:876 E:879 ||| TO
assess  ||| S:879 E:886 ||| VB
the  ||| S:886 E:890 ||| DT
current  ||| S:890 E:898 ||| JJ
status  ||| S:898 E:905 ||| NN
of  ||| S:905 E:908 ||| IN
palliative  ||| S:908 E:919 ||| JJ
care  ||| S:919 E:924 ||| NN
and  ||| S:924 E:928 ||| CC
recommend  ||| S:928 E:938 ||| VB
modifications  ||| S:938 E:952 ||| NNS
to  ||| S:952 E:955 ||| TO
the  ||| S:955 E:959 ||| DT
NCCN  ||| S:959 E:964 ||| NNP
Guidelines  ||| S:964 E:975 ||| NNS
based  ||| S:975 E:981 ||| VBN
on  ||| S:981 E:984 ||| IN
the  ||| S:984 E:988 ||| DT
unique  ||| S:988 E:995 ||| JJ
needs  ||| S:995 E:1001 ||| NNS
of  ||| S:1001 E:1004 ||| IN
the  ||| S:1004 E:1008 ||| DT
region ||| S:1008 E:1014 ||| NN
.  ||| S:1014 E:1016 ||| .
